Home ›
Trademark Categories ›
Pharmaceuticals ›
2001 ›
MA ›
MAXASTA
Trademark search for:
MAXASTA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2005-06-21 — Application filed
2005-06-27 — Application filed
2006-01-11 — Assigned to examiner
2006-01-12 — Final disposition recorded
2006-01-12 — Final disposition recorded
2006-01-13 — Paper received
2006-01-13 — Correspondence received in law office
2006-02-01 — Amendment from applicant entered
2006-02-02 — Approved for pub - principal register
2006-02-03 — Assigned to lie
2006-02-08 — Law office publication review completed
2006-02-14 — Assigned to examiner
2006-03-01 — Notice of publication
2006-03-21 — Published for opposition
2006-06-13 — Noa mailed - sou required from applicant
2006-12-12 — Sou teas extension received
2006-12-12 — Sou extension 1 filed
2007-02-15 — Sou extension 1 granted
2007-05-03 — Sou teas extension received
2007-05-03 — Sou extension 2 filed
2007-05-03 — Sou extension 2 granted
2007-12-11 — Sou teas extension received
2007-12-11 — Sou extension 3 filed
2007-12-11 — Sou extension 3 granted
2008-06-16 — Final status recorded
2008-08-15 — Application abandoned
2008-08-15 — Application abandoned
Owner Information
Swiss Pharmaceutical Industries S.A.
Neuchatel CH
Swiss Pharmaceutical Industries S.A.
Neuchatel CH
Correspondent
Mark I. Peroff Kirkpatrick & Lockhart Preston Gates Ellis LLP 599 LEXINGTON AVE NEW YORK, NY 10022-6030 UNITED STATES
Filing Details
Filing Date:
2005-06-21
Status Date:
2008-06-16
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.